U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologics License Application (sBLA) for PALYNZIQ® ...

LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported fourth-quarter and full-year 2025 results and issued full-year 2026 guidance.

GRAIL: A Major Trial Disappointment

GRAIL's topline results from the NHS-Galleri trial were a clear disappointment with no major implications on commercialization. Read why GRAL stock is a hold.
IEEE

CT saturation calculations - are they applicable in the modern world? - part IV: CT sizing as per IEC standards and the benefits of non conventional instrument transformers

Abstract: The previous parts of this series of papers was dedicated to current transformers (CTs) designed and tested according to ANSI standards. The determination and specification of CTs for ...
PharmiWeb

Pharmacy Automation Market Report with Statistics, Growth, Opportunities, Sales, Trends Service, Applications and Forecast 2029

The global pharmacy automation market is projected to grow at a CAGR of approximately 9–10% through 2029. This growth is driven by increasing awareness of pharmacy automation, rapid decentralization ...